Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
That’s what happens after a real company with real science goes through an orchestrated Bear Raid. As I said real companies crush the shorts while fraudulent companies get crushed.
Waiting for the buying show Moneycrew. Bring it on!
I’m not expecting any news from NP. The show is simply bringing purchasing power. Just like Short power there is Long power. What comes around goes around.
Great. I look forward to watching the show.
Good for you. What goes around comes around.
Lorabas, That’s the bottom line. I’m not selling a single share. This is a buying opportunity.
Seen this type of orchestrated fear-mongering many times. If your real you end up crushing the shorts. If your not you never recover.
Been here 7 years and know Leronlimab has real value even if only in HIV space. Cancer is a big bonus that looks promising but we are not reliant on delivering a blockbuster to go to $5 plus. So why would any Long sell if they are truly Long? Fear.
The NP attack is the best fear story the shorts can build so their pumping air into that balloon as fast as they can because it’s non consequential at the end of the day.
Well, you’d never know it by your posts.
So when we receive FDA Approval for HIV Combo will that mean the FDA is a scam also. Obviously you are spewing trash to further your cause.
Agree on all points Tony. It will be a great relief when this company is hopefully acquired. Nader has aged me and I will be at peace when he is no longer attached to my financial future. As good as the science is he just can’t seem to get out of the way.
They have their stops in place. Mid 20’s and they will cover and decide to continue their next move. Drug Doctor is doing his best with his charts and shenanigans to scare all the longs into thinking this is going to return to .50 or lower. I’m not biting.
Grip, it’s a typical hit piece from a non credible source timed with a Bear Raid. Reminds me of AF, the master of twisting the facts and orchestrating a sell off. Culper accomplished it’s short term job of creating fear. If you peel another layer of the onion back you will see the results that Culper Research has had on SP, an average uptick of 40%. Let’s see how this plays out. Perhaps we should be thanking them for creating further validation.
This is all part of the journey. We are on the radar at a much different level than early December and this is part of the coming out party.
The reality is when the stock takes a hit everybody want to blame somebody and in this case it’s Nader and the delayed BLA. The Bear Raid was coming regardless because the statistics made sense to orchestrate. It won’t be the last time, it’s the beginning of the bumpy road to running the SP forward to an uplist.
Long’s have to remain centered on the facts and ignore the knee jerk reaction of panic. I always ask myself waist has changed. Many more catalysts then yesterday but the delayed BLA is going to take the headlines.
I get it. Winning is always exciting. My only objection to this type of investing is when accompanied by an unsubstantiated hit piece. I’m very Long and will be here until our valuation matches the science.
Short attacks are all part of the journey and will ultimately push the SP even harder at some point in the game. If we had a hot air ballon for science I’d be worried and would have exited at $1.50.
Hopefully you won’t push your luck when we really move. Oh well easy come easy go. No difference in my wallet until I cash out.
Thanks for the play by play. You should call horse racing.
Been on this side of a Bear Raid more than once. This is the kind of thing AF orchestrated except it’s not AF obviously.
Culper Research, a phantom company with a track record of ultimately driving SP up because smoke and mirrors have no long term impact other than bringing awareness to the facts.
Culper Research, if you can call it that, actually has a history of putting out 10 point hit pieces at the worst possible time. The reason is the complete and utter lack of fundamental analysis which we will get to later on. The company has no about us, no names on the report, no location of their operation, essentially no accountability. Investor’s need to watch out for mudslingers that are ghosts and DO NOT EXIST.
Let’s look at their past 4 deals.
It’s actually impressive with these results that any of their “clients” still have money left. They average close to a 40% LOSS on every position.
Ghost Company => No Accountability => No Credibility
There is no management, no contact number, just a twitter address linked to the website. The web presence was created on 6/18/19. The author is anonymous and trying to instill fear to make a buck but has one of the worst track records. So when you cannot be touched by the arms of the law they have no problem breaking it and committing slander toward a CEO trying to make a difference in cancer patients lives. Any investor that is swayed by these falsehoods should understand that Cluper Research has a blatant agenda of shorting and distorting.
I have a relationship with Craig Eastwood. I forwarded the report.
I was not able to listen to the call live. I listened to the call tonight before reading the reactions here on iHub so that I wouldn’t have a bias.
Couldn’t agree more Blane. I just don’t get all the doom and gloom. Maybe y’all should join the shorts and throw the towel in. The BLA isn’t going to be completed until the end of February. OMG we are fricking done, the stock is going to tank. Really!!!! Oh yeah run for the exits. Wouldn’t surprise me if that prediction is dead wrong. Grip, you are about as emotional investor as I’ve ever seen leading the doom charge...WTF. Get a Grip-your not long your the flavor of the day.
Bottom line is the science continues to impress and Nader continues to move forward.
I have been as critical as anyone about Nader and he has his short comings-it’s called add some leeway on my forecast dates for getting things done because the variables cannot be controlled. He is not the best at building the unknown into the equation. Is he my choice for CEO- No. However he is our CEO and as committed and forthright as we could hope for. He will not turn his back on we the SH’s that have wagered our hard earned $ on Leronlimab.
Onward and upward folks. Nothing’s changed except we have more bridges to cross after a SP correction. Time to buy, buy, buy. This science is going to kick these shorts right in the balls.
Thanks BL. Your speculation is logical. Here’s to you becoming a bored retired lawyer.
That’s the million $ question. Why take a chance on compromising the best response possible? There has to be a logical explanation.
LM, thank you for leading this charge.
I am at a loss as to why Nader and his approval boys feel they are entitled to millions of shares for performing duties they are already being compensated for.
Even if the outcome is a buyout for $15 plus/$10B they don’t deserve to dive that deep into the cookie jar.
My concern right now is Nader staying on point and taking care of business. Complete the BLA and secure non dilutive financing. The cart is in front of the horse once again.
Tomorrow’s CC better be all we expect and more.
I ’m not a pumper, I’m not a day trader, I’m an investor that understands what we legitimately have.
You have shown no information other than generalizations to support your short thesis. What you have proven is you know very little about Leronlimab and the catalysts driving the stock. Oh, and the Conavirus has nothing to do with our SP.
Unfortunately for you your short position is based on statistics of what happens to Biotech OTC stocks when they run up into the RSI danger zone it’s called short the stock because the odds say your going to be right. The hole in your blanket strategy is your hooked into a big ole whale not some snag on the bottom of the ocean. When this pulls back your gonna be pulled overboard.
What is your purpose for being here? Are you trying to save us all from the ravages of biotech investing?
Either bring some new material that has value or leave. I don’t want to hear another word about your shoe deal. Sounds like a great investment for you. Fine I’ll respect that but not interested. In fact nobody here on the CYDY board is. Take your dialogue home to your Renewable Energy Investors.
To say my patience has been tried over the past seven years is an understatement. However, we are now on the cusp of pushing this much more robust platform science than I initially invested in over the top of what has been a very long trek. It’s going to happen although not without a bit of stumbling.
“Hope for the best for your stock but looks rather stuck in mud. Something will need to give soon one way or the other.”
Look at the 60 day chart and tell me this stick is stuck in the mud. Given the multiple near term catalysts this is like a marble in a slingshot being held back.
Once again this is a real drug that will be approved for HIV Combo this year not some fraud. We are at the tip of the iceberg.
Get on the bus before the next breakout. It’s coming sooner than later.
Just a little humor Tony. I get the pathway and financing that needs to come and I think it will. We have the results coming in to attract the $. As you said BTDX raised $200M with not near as much meat. BLA filing and continued positive cancer results are going to both attract the financing and elevate the SP for an uplist.
We are months away from accomplishing this.
HUGE is the word of the day, week, month, year....
Just raising enough to get to the $40-$50M non dilutive financing. Nader is not good at meeting deadlines but he is good at doing what he says he is going to do - we just don’t know exactly when that will be.
IMO BLA is going to be completed in February - I know, way to go out on a limb.
Of more importance are the continued cancer results and injecting of new patients.
On the FDA front... Type C meeting and BTD outcome due by March 20.
We will gain a little more clarity on the Thursday CC.
One can feel the upward pressure on the SP - the cancer results are a constant SP driver that will only let up if the results drastically change.
Could be a hand that continue to deal 21 over and over again. Weekends are not near as much fun as M-F where we get to find out what the excitement for the day will be. A positive PR, more patients with hope, more Short’s figuring out they should be Long, NP’s weekly talk show with Christine, and Grip telling people to simmer down. Gotta love the whole gig that is going on with CYDY.
Do you read the posts on this board? The catalysts and science are reinforced every day. These are not wishful milestones, they are near term milestones that are going to propel the SP to an organic uplist. I know you don’t believe this is real. Even without our promising cancer results we have a drug that is 99% guaranteed to get FDA approval and begin generating revenue this year. The HIV Combo approval is going to pave the way for our HIV Mono approval. HIV is going to deliver $10 SP all by itself. You want to keep shorting by all means go ahead. The way cancer is looking the SP is going to continue running regardless of being over bought. What I’m saying is you have a conditioned perspective about the OTC combined with a strategy that makes sense and makes $. The flaw is it doesn’t apply to CYDY.
Tired of the noise. Going up tomorrow.
That is exactly correct ohm. Thanks for setting this straight.
Yeah, be careful or the Admin will shut you down. For whatever reason it’s not a level playing field.
Well said. None of the short talkers stay longer than a couple weeks before they get burned. This is the start of a journey that will continue to attract traders that mistakenly see a big fat pig that is waiting to be slaughtered.
Overvalued. You obviously don’t know the first thing about how to value a pre revenue biotech.
This is a horse of a different color. Take off your sunglasses dude.
What? Is she your girlfriend?
I’m really interested in seeing what happens the last 30 minutes before the market closes for the weekend. If we get a rip up it will be a nice set up for next week.
From a macro perspective it doesn’t matter. This is looking like a grand slam. Just keep the pristine cancer results coming in.
Good post from TechGuru
I posted earlier and it was deleted because it contained a link - so posting again.
Posted By: TechGuru
These are extraordinary news. Statistically speaking, we have today probed that we are a bona fide Oncology company. Period.
My read from communication (it was crafted a bit awkwardly for us investors, but from the trial progression perspective it makes sense) :
Patient #1: New data from the first patient enrolled in the Company’s mTNBC Phase 1b/2 trial showed no detectable levels of circulating tumor cells (CTC) with leronlimab in combination with carboplatin at 16 weeks of treatment
Patient #3: New data from the second patient enrolled in the Company’s mTNBC Phase 1b/2 trial showed no detectable levels of CTC with leronlimab in combination with carboplatin after two weeks of treatment. This patient also showed a 70% reduction in EMT cells after just two weeks of treatment.
Patient#4: Initial data from the third patient in the mTNBC trial indicated the CTC dropped to zero after two weeks of treatment with leronlimab.
Patient #2 (M-i-l) : New findings from the patient enrolled through an emergency investigational new drug (IND) with stage 4 HER2+ MBC that has metastasized to the liver, lung and brain, demonstrate no new metastasis in the brain after treatment with leronlimab as the only product for the metastasis to her brain. Prior to enrolling in the trial, the patient had 18 identifiable tumor spots in the brain. Today, following two months of weekly 700 mg doses of leronlimab, there are only three identifiable lesions, as seen in an MRI. This patient’s radiologist cancelled the suggested new round of radiation due to results that he believes is due only to leronlimab.
A very long while would be in your best interests.
Hope you can too. Saw you pop up on the board with your bullish sentiment. Never know what intent is behind the words. Welcome aboard. Been invested for seven years. Lucky you walking into this treasure at the right time.
IMHO Could go over $2 today.